Form 4: Molina Healthcare Executive James Woys Reports Stock Transactions
SEC Form 4 Filing
Chief Operating Officer James Woys of Molina Healthcare reports acquisition and disposal of company stock related to performance stock units and restricted stock grants.
Summary
- James Woys, Chief Operating Officer of Molina Healthcare, filed a Form 4 detailing changes in beneficial ownership of company stock.
- On March 1, 2024, Woys acquired 11,473 shares of common stock at $387.21 per share as settlement of performance stock units that vested at 170% achievement level based on the company's averaged achievement of adjusted net income per share in the three fiscal years of 2021, 2022, and 2023.
- Also on March 1, 2024, 4,515 shares were disposed of to cover withholding taxes related to the vesting of the performance stock units at $387.21 per share.
- An additional 1,423 shares were disposed of to cover withholding taxes arising in connection with the vesting of 4,594 shares on March 1, 2024 at $387.21 per share.
- Woys also acquired 4,649 shares of restricted stock under the company's 2019 Equity Incentive Plan at $387.21 per share.
- Following these transactions, Woys beneficially owns 63,613 shares of Molina Healthcare common stock.
- A power of attorney document is included, authorizing Jeff D. Barlow and Codruta Boggs to act on behalf of James Woys for Section 16(a) filings.
Sentiment
Score: 7
Explanation: The document indicates positive performance through the vesting of performance stock units at a high achievement level. The grant of restricted stock is also a positive sign. However, the document is primarily a regulatory filing, so the sentiment is moderately positive.
Positives
- The vesting of performance stock units at 170% suggests strong performance relative to targets.
- The grant of restricted stock indicates continued alignment of executive incentives with shareholder value.
Future Outlook
The vesting schedule of the restricted stock indicates a multi-year alignment of the executive's interests with the company's performance.
Industry Context
Form 4 filings are standard practice for reporting insider transactions and are closely watched by investors for insights into management's view of the company's prospects.
Comparison to Industry Standards
- Vesting schedules and equity incentive plans are common across the healthcare industry to attract and retain top talent.
- Companies like UnitedHealth Group, Anthem (now Elevance Health), and Humana also utilize similar equity-based compensation strategies.
- The 170% achievement level for performance stock units suggests Molina Healthcare exceeded its financial targets during the performance period, which is a positive signal compared to peers with lower achievement rates.
Stakeholder Impact
- Shareholders may view the vesting of performance stock units at 170% as a positive indicator of company performance.
- Employees may be motivated by the company's achievement of its financial targets.
- The transactions have no immediate impact on customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 2018-05-08 | Date of the Limited Power of Attorney for Section 16(a) Filings |
| 2021-03-01 | Date of grant of performance stock units that vested on March 1, 2024 |
| 2024-03-01 | Date of stock transactions: acquisition of shares from performance stock units, disposal of shares for tax withholding, and grant of restricted stock. |
| 2024-03-05 | Date of signature on the Form 4 filing. |
| 2025-03-01 | First vesting date for one-third of the 4,649 newly granted restricted shares and vesting date for 3,093 additional shares. |
| 2026-03-01 | Second vesting date for one-third of the 4,649 newly granted restricted shares and vesting date for 1,704 additional shares. |
| 2027-03-01 | Final vesting date for one-third of the 4,649 newly granted restricted shares. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.